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The inaugural robot-assisted urological procedure in a child was performed in 2002. 
With more than a decade having passed since this milestone operation, this study 
aims to catalogue the impact of this technology by utilizing bibliographic data as a 
surrogate measure for global diffusion activity and to appraise the quality of evidence 




A systematic literature search of multiple electronic databases and grey literature 
sources was performed to retrieve all reported cases of pediatric robot-assisted 
urological surgery published between 2003 and 2015. The status of scientific 
community acceptance was determined using a newly developed and validated 




A total of 129 publications were identified that reported 3228 procedures in 2958 
patients. The most reported procedures were pyeloplasty (n = 1718) and ureteral 
reimplantation (n = 929). There were 14 countries and 41 institutions represented in 
the literature, with the majority of publications contributed by North American 
institutions. On average, the total case volume reported in the literature more than 
doubled each year (mean value increase 250.6% per annum). The level of evidence 
for original studies remains limited to case reports, case series and retrospective 
comparative studies (Level III – IV evidence). Lack of convergence on Progressive 
Scholarly Acceptance charts indicates that robot-assisted techniques for pyeloplasty 
or ureteral reimplantation have not been accepted by the scientific community, and 




Global adoption trends for robotic surgery in pediatric urology have been progressive 
but remain low volume. Pyeloplasty and ureteral reimplantation are dominant 
applications. Robot-assisted techniques for these procedures are not supported by 
high quality evidence at present. Next-generation surgical robots are forecast to be 
smaller, cheaper, more advanced and customized for pediatric patients. Ongoing 





It is a duty of clinical governance to monitor adoption processes for new technology 
items in healthcare (1). On a global scale, inter-country differences in regulation 
approval policy, health system models and economics influence the already 
complicated and intriguing factors that drive the diffusion of healthcare innovation (2). 
In parallel with evidence-based scrutiny of safety, quality and cost-effectiveness; it is 
important to also maintain ongoing assessment of technology adoption patterns in 
order to understand the scale and pace of change on a field of clinical practice.  
 
Robot-assisted surgery has been one of the major technology items introduced to 
pediatric urology in the 21st century. Robot-assistance has not yet enabled novel 
procedures, but instead has offered an alternative mode to undertake existing 
minimally invasive surgical approaches. Technological enhancements provided by 
robot-assistance are promoted as offering improved operative performance 
capabilities and enabling minimally invasive approaches when they might otherwise 
not be considered (1, 3-5).  
 
Anecdotally, adoption of robot-assisted surgery has continued to promulgate in 
pediatric urology since it was first introduced in March 2002 when Peters et al 
performed a robot-assisted laparoscopic pyeloplasty (1, 6, 7). Several recent studies 
have interrogated major nationwide administrative databases in North America to 
empirically confirm increasing popularity of robot-assisted surgery in pediatric urology 
within this geographical region (8-10). In the absence of global registries for robot-
assisted pediatric urological surgery, this study utilizes bibliographic data as a 
surrogate measure for global technology diffusion activity and quality of evidence. 
The status of scientific community acceptance for robotic surgery in pediatric urology 
was determined using a newly developed and validated analysis model named 
Progressive Scholarly Acceptance (11, 12). 
 
 




A systematic literature search of multiple electronic databases and grey literature 
sources was performed to retrieve all reported cases of pediatric robot-assisted 
urological surgery. The search strategy previously described by Cundy et al was 
replicated, with extensions to include literature from 2003 to 2015 inclusively, and 
limitation to urological procedures only (1). Two reviewers (SJDH, TPC) screened 
identified articles independently for relevance, with disagreements resolved by 
consensus. Due to inability to account for duplication of separately published data, 
studies reporting aggregated data from nationwide inpatient databases such as the 
Pediatric Health Information System, Kids’ Inpatient Database, and Perspective 
database were excluded. Numerous data items were extracted from all included 
studies for tabulation. These data included patient numbers, procedure types, study 
design, geographical detail of institutional affiliations, and patient demographic 
details. 
 
Progressive Scholarly Acceptance 
 
The Progressive Scholarly Acceptance model is based the theory by Riskin et al that 
characterises evolution of an innovation (or any other new diagnostic or treatment 
item) into an “expanding period” and “refining period” (13). The former typically 
represents an earlier experimental phase, and the latter represents a more matured 
period of establishment through iterative clinical and scientific endeavour. Some 
innovations promptly transition between periods, while others “fail” and never reach a 
period transition point. Methodology for the Progressive Scholarly Acceptance metric 
is centred on bibliometric analysis and is described by detail by Schnurman et al (11, 
12). Progressive Scholarly Acceptance models were separately performed post-hoc 
for pyeloplasty and ureteral reimplantation, as these procedures were identified as 
the dominant applications for robot-assisted surgery in pediatric urology. All relevant 
studies identified in the above search strategy were coded as either an “initial 
investigation” or “refining study” using the criteria outlined by Schnurman et al (11, 
12). Both annual and compounding models were calculated. The compounding 
model is more conservative and used to determine the Progressive Scholarly 
Acceptance end-point whereby the number of “refining study” articles surpasses the 
“initial investigation” articles (11, 12). This transition point indicates an interval from 
which the majority of literature represents refinement in clinical practice, implying that 






A total of 129 publications were identified that reported 3228 procedures in 2958 
patients. The most reported robotic-assisted urological procedures in children were 
identified as pyeloplasty (n = 1718) and ureteral reimplantation (n = 929). These two 
procedures predominate the literature and together represent 82% of reported case 
volume. Further breakdown of variety of reported procedures and respective case 
volumes is summarised in Table 1. There were 14 countries and 41 institutions 
represented in the literature, with the majority of publications contributed by North 
American institutions (Figure 1). The youngest patient identified was 1 month of age 
(14) and smallest patients weighed 4 kilograms (14, 15).  
 
There was a progressive trend of increasing volume of reported procedures per 
annum over the examined period (Figure 2a). This trend pattern was similar for the 
number of relevant publications per annum (Figure 2b). On average, the total case 
volume reported in the literature more than doubled each year (mean value increase 
250.6% per annum). The cumulative number of reported procedures increased by a 
mean value of 233.1% per annum. The level of evidence for original studies is limited 
to case reports, case series and retrospective comparative studies. No data was 
collected entirely prospectively and no randomized controlled trials were identified 
(Figure 2c). The temporal distribution pattern of literature quality of evidence was 
multimodal, with an early peak of case reports followed by later peaks of case series 
and comparative studies (Figure 2c). Progressive Scholarly Acceptance charts 
indicated that the scientific community has not accepted robot-assisted techniques 
for pyeloplasty or ureteral reimplantation (Figures 3b and 3d). Lack of convergence 





Based on bibliographic data, global adoption trends since the introduction of robotic 
surgery in pediatric urology are progressive, but unimpressive compared to other 
specialty fields such as adult urology. The pattern of case volume reported over time 
corresponds with the early phases of the S-shaped diffusion of innovation curve 
described by Rogers (5, 16). The highly varied case-mix in the literature is almost 
entirely comprised of reconstructive procedures. This is expected and reflective of 
the characteristic nature of surgery encountered in pediatric urology. Amongst the 
case-mix identified, pyeloplasty and ureteral reimplantation are dominant and 
together account for an overwhelming majority proportion of reported procedures. 
Progressive Scholarly Acceptance analysis indicates that these indications have not 
been accepted by the scientific community and remain in an “expanding period” of 
early adoption. While pyeloplasty and ureteral reimplantation applications do seem to 
continue to thrive, others have proven to be either rare or experimental, and 
therefore remain isolated amongst numerous singular procedures reported in the 
literature. Specific roles and case selection for robot-assisted techniques are yet to 
be clearly defined. This is reflected in the evolving characteristic of literature that in 
recent years has included series of increasingly complex operations such as revision 
surgery (17), simultaneous bilateral procedures (18) and procedures on younger 
patients (19-22). 
 
Robot-assisted surgery is promoted as an enabling technology that permits the 
reduced morbidities of minimally invasive techniques with clinical outcome benefits of 
“gold-standard” open techniques. Conventional laparoscopic pyeloplasty and ureteral 
reimplantation have achieved limited adoption worldwide despite these techniques 
existing for almost 20 years. Reasons for limited uptake are attributed to the inhibitive 
degree of technical difficulty associated with complex reconstructive surgery that 
includes abundant intracorporeal suturing (4, 23, 24). The enhanced dexterity, 
precision, ergonomics and optics facilitated by robot-assistance are perceived to 
democratize minimally invasive surgery by making it more widely achievable. Studies 
of subscription-based administrative databases in North America confirm increasing 
rates of minimally invasive pyeloplasty and ureteral reimplantation, with robot-
assisted approaches being performed up to 4 times more often than the conventional 




In a broader perspective, the uptake of robotic technology in pediatric urology is 
circumspect when considered in the context of more than 3 million laparoscopic 
procedures having been performed worldwide using the da Vinci Surgical System 
(Intuitive Surgical, CA) platform. In adult urology, a number of procedures such as 
robot-assisted laparoscopic prostatectomy are now considered standard of care in 
some countries (26). This degree of technology impact is not foreseeable in pediatric 
urology, especially when the literature informs us that only 41 institutions worldwide 
are performing robot-assisted urological surgery in children. Interestingly, the 
pervasiveness of technology diffusion for robot-assisted laparoscopic prostatectomy 
occurred without the support of high level of evidence data. It was only in 2016 that 
the first and only randomized controlled trial was published for this indication. This 
trial identified statistically non-significant differences in primary outcomes at 12 
weeks post-operatively (27). Evidence examining the use of pediatric robot-assisted 
urological surgery is of limited quality and restricted to Level III to IV based on the 
Oxford Centre for Evidence-Based Medicine (OCEBM) classification system. Most of 
the published literature is case reports (27/129; 20.9%) and case series (75/129; 
58.1%); however has been improvement in the quality of evidence demonstrated by 
the publication of 21 original comparative studies between 2011 - 2015 compared to 
just 6 between 2003 - 2010. Emerging high quality evidence indicates that outcomes 
for robot-assisted pyeloplasty (3, 9, 10) and ureteral reimplantation (28, 29) are 
largely comparable to open techniques. With this evidence failing to support 
meaningful outcome benefits for these dominant indications, a period of critical 
assessment must occur as a priority in order to more definitively inform the debate 
regarding the clinical role and cost-effectiveness of this technology in pediatric 
urology (30). Higher quality evidence must be aspired towards, and is achievable as 
demonstrated by the above-mentioned randomized controlled trial that has 
threatened to cause interruption to the previously uninterrupted diffusion of robot-




Healthcare spending is under intense pressure of budget restraints and prioritized 
distribution of resources. Medical care has arguably never been more expensive. 
Any new technology in a modern healthcare system faces mounting pressure to 
prove cost-effectiveness. There were only several publications identified in this 
systematic review that investigated cost-effectiveness (32). Interestingly, a recent 
cost-analysis study by Tedesco et al identified that an annual case volume of 349 
procedures was required to meet break-even costing and financially justify 
establishment of a pediatric robotic surgery program in their healthcare setting (33). It 
is unlikely that this caseload would be achievable in a single tertiary pediatric center. 
High expenses of existing robotic systems are a major barrier to accessibility and are 
widely regarded as the most limiting factor of this technology (2). Given the almost 15 
year period since robot-assisted surgery was introduced to pediatric urology, it is 
surprising that this literature field is represented by less than 50 institutions. Financial 
affordability must be prioritized to broaden clinical accessibility. In the coming years 
we can expect to see robot-assisted laparoscopic surgery become less synonymous 
with the da Vinci Surgical System (Intuitive Surgical, CA, USA) (34). Expiry of 
patents and growing presence of legitimate market competitors are increasingly 
threatening to radically diversify robotic technology in minimally invasive surgery.  
Future robotic technologies are forecast to not only be more affordable, but also 




Operative domain is a major challenge. Many authors describe age (> 4 years) and 
bladder size (> 200ml) criteria for intravesical (Cohen technique) robot-assisted 
laparoscopic ureteral reimplantation eligibility (4, 24, 35). Workspace restrictions for 
5mm and 8mm da Vinci instruments in laparoscopic surgery have also been 
empirically tested in a laboratory setting (36). In this pre-clinical randomized 
crossover study, 3mm non-robotic laparoscopic instruments outperformed 5mm and 
8mm robotic instruments for advanced bimanual operative tasks in constrained 
workspace volumes < 200cm3 (36). Instrument size and design clearly is critically 
important for reconstructive surgery in confined operative domains that characterizes 
laparoscopic pediatric urology surgery. Currently available robotic instruments are 
fundamentally designed for the adult patient, and confine many robot-assisted 
urological procedures to older children with larger operative workspace volumes. 
There is a need for next-generation robotic technology to be further optimized for 




There are limitations of this study that are implicit with publication bias associated 
with bibliographic data. Firstly, we rely on this data being fairly representative as a 
surrogate of actual surgical activity on a global scale. While the proportion of 
reported and unreported robot-assisted surgical activity is unknown, we consider it 
appropriate to expect that the rate of reporting is consistent and thus interpretation of 
trends are reliable. Bibliographic analysis, including the Progressive Scholarly 
Acceptance model, has previously been validated as a reliable measure to quantify 
innovation in surgical practice (11, 12, 37). Secondly, there is an inevitable delay 
between surgical activity and literature reporting that must be appreciated when 




Global adoption trends for robotic surgery in paediatric urology have been 
progressive but remain low volume in the context of overall surgical activity in this 
specialty, and compared to other specialties such as adult urology. Pyeloplasty and 
ureteral reimplantation are the overwhelmingly dominant applications for this 
technology at present. Robot-assisted techniques for these procedures are yet to be 
supported by high quality evidence from comparative studies or trials. The overall 
quality of evidence in the literature for this field is poor and predominantly 
represented by case reports and case series. It must be acknowledged that current 
surgical robots are first-generation technology. Next-generation technology is already 
under development and is forecast to be smaller in footprint, cheaper, more 
advanced and customized for paediatric patients. It will be important to ensure that 




 n Procedure 
1718 Pyeloplasty 
929 Ureteral reimplantation 
117 Nephrectomy, nephrouretetectomy 
113 Heminephrectomy 
97 Mitrofanoff appendicovesicostomy 
90 Ureteroureterostomy 
22 Orchidopexy 
19 Bladder diverticulectomy 
18 Augmentation cystoplasty 
17 Retrovesical remnant excision  
15 Ureterocalicostomy 
9 Pyelolithotomy 




7 Bladder neck sling cystourethropexy 
7 Oncological 
4 Distal ureterectomy (ectopic ureteral stump) 
3 Fibroepithelial polyp excision 
3 Peri-renal lymphangioma excision 
1 Renal vascular hitch (transposition of crossing vessels) 
1 Hypospadias repair 
1 Sigmoid vaginoplasty 
1 Gonadal vein ligation (gonadal vein syndrome) 
1 Megaureter tapering 
1 Nephropexy 
1 Hysterectomy, gonadal biopsy and orchidopexies (mullerian duct 
syndrome) 
1 Excision of bladder duplication 
Total = 3228  
 




Figure 1. Geographical distribution of publication volumes (n) for pediatric robot-
assisted urological surgery (n = 129 total).  
  
 
Figure 2. Case volume (a), and publication volume (b), and publication 
characteristics (c) per annum reported in the literature for pediatric robot-assisted 





Figure 3. Progressive Scholarly Acceptance charts for pyeloplasty (annual and 
compounding, A and B respectively) and ureteral reimplantation (annual and 
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